Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...

Explore last week's key healthcare market trends, top gainers & losers, major deals, Trump's tariff plans, FDA approvals, and significant legal updates.

FDA head Marty Makary said the agency may fast-track drugs from companies that “equalize” the cost of medicines between the U ...

The Delaware Supreme Court ruled in favor of companies including GSK (NYSE:GSK), Pfizer (NYSE:PFE), and Boehringer Ingelheim ...